Cargando…
Aptamer-siRNA Chimeras: Discovery, Progress, and Future Prospects
Synthetic nucleic acid ligands (aptamers) have emerged as effective delivery tools for many therapeutic oligonucleotide-based drugs, including small interfering RNAs (siRNAs). In this review, we summarize recent progress in the aptamer selection technology that has made possible the identification o...
Autores principales: | Kruspe, Sven, Giangrande, Paloma H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618303/ https://www.ncbi.nlm.nih.gov/pubmed/28792479 http://dx.doi.org/10.3390/biomedicines5030045 |
Ejemplares similares
-
A Universal Protein Tag for Delivery of SiRNA-Aptamer Chimeras
por: Liu, Hong Yan, et al.
Publicado: (2013) -
EpCAM Aptamer-siRNA Chimera Targets and Regress Epithelial Cancer
por: Subramanian, Nithya, et al.
Publicado: (2015) -
STAT3 Gene Silencing by Aptamer-siRNA Chimera as Selective Therapeutic for Glioblastoma
por: Esposito, Carla Lucia, et al.
Publicado: (2017) -
Elimination of HER3-expressing breast cancer cells using aptamer-siRNA chimeras
por: Nachreiner, Inga, et al.
Publicado: (2019) -
Aptamer-siRNA chimera and gold nanoparticle modified collagen membrane for the treatment of malignant pleural effusion
por: Chen, Wen, et al.
Publicado: (2022)